Clinical Trials Logo

Clinical Trial Summary

Drug eluting stents significantly reduced the rate of in-stent restenosis in coronary arteries. There are several kinds of DES i.e. eluting the drug either from stable or biodegradable polymer. The type of the polymer may impact the clinical outcome. The aim of our study was to compare safety and efficacy of implantation of two different types of stents eluting paclitaxel from stable vs biodegradable polymer (TAXUS stent vs LUC-CHOPIN stent) into coronary artery by-pass graft.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Stenosis in Saphenous Vein Graft, Drug Eluting Stent

NCT number NCT00766129
Study type Interventional
Source Institute of Cardiology, Warsaw, Poland
Contact
Status Active, not recruiting
Phase Phase 3
Start date February 2008
Completion date December 2011